Diagnostic and Prognostic Role of 18F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept

被引：0
|
作者：
Fiz, Francesco [1 ]
Bottoni, Gianluca [1 ]
Treglia, Giorgio [2 ,3 ,4 ]
Trimboli, Pierpaolo [4 ,5 ]
Piccardo, Arnoldo [1 ]
机构：
[1] EO Osped Galliera, Dept Nucl Med, I-16128 Genoa, Italy
[2] Ente Osped Cantonale, Imaging Inst Southern Switzerland, Clin Nucl Med, CH-6500 Bellinzona, Switzerland
[3] Univ Lausanne, Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, CH-1011 Lausanne, Switzerland
[4] Univ Svizzera Italiana, Fac Biomed Sci, CH-6900 Lugano, Switzerland
[5] Ente Osped Cantonale, Lugano & Mendrisio Reg Hosp, Clin Endocrinol & Diabetol, CH-6500 Bellinzona, Switzerland
来源：
JOURNAL OF CLINICAL MEDICINE | 2022年 / 11卷 / 13期
关键词：
ESTROGEN-RECEPTOR; HORMONE-THERAPY; DISCORDANCE; TOMOGRAPHY;
D O I：
10.3390/jcm11133589
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] 18F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients
    Nienhuis, Hilde H.
    van Kruchten, Michel
    Elias, Sjoerd G.
    Glaudemans, Andor W. J. M.
    de Vries, Erik F. J.
    Bongaerts, Alfons H. H.
    Schroeder, Carolien P.
    de Vries, Elisabeth G. E.
    Hospers, Geke A. P.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (08) : 1212 - 1218
  • [22] Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET
    Gennari, A.
    Brain, E.
    De Censi, A.
    Nanni, O.
    Wuerstlein, R.
    Frassoldati, A.
    Cortes, J.
    Rossi, V.
    Palleschi, M.
    Alberini, J. L.
    Matteucci, F.
    Piccardo, A.
    Sacchetti, G.
    Ilhan, H.
    D'Avanzo, F.
    Ruffilli, B.
    Nardin, S.
    Monti, M.
    Puntoni, M.
    Fontana, V.
    Boni, L.
    Harbeck, N.
    ANNALS OF ONCOLOGY, 2024, 35 (06) : 549 - 558
  • [23] Evaluation of tumour heterogeneity by 18F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment
    Cheng Liu
    Shihui Hu
    Xiaoping Xu
    Yongping Zhang
    Biyun Wang
    Shaoli Song
    Zhongyi Yang
    Breast Cancer Research, 24
  • [24] The predictive value of early changes in 18F-fluoroestradiol PET/CT during fulvestrant 500 mg therapy in patients with ER-positive metastatic breast cancer
    He, M.
    Liu, C.
    Yang, Z. -Y.
    Liu, G. -Y.
    Zhang, Y. -J.
    Wang, Z. -H.
    Shao, Z. -M.
    BREAST, 2019, 44 : S58 - S58
  • [25] 18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER1/HER22-Metastatic Breast Cancer
    Peterson, Lanell M.
    Kurland, Brenda F.
    Yan, Fengting
    Novakova-Jiresova, Alena
    Gadi, Vijayakrishna K.
    Specht, Jennifer M.
    Gralow, Julie R.
    Schubert, Erin K.
    Link, Jeanne M.
    Krohn, Kenneth A.
    Eary, Janet F.
    Mankoff, David A.
    Linden, Hannah M.
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) : 184 - 190
  • [26] Pilot study to evaluate circulating tumor DNA (ctDNA) to PET/CT imaging using 18F-Fluorodeoxyglucose (FDG) and 18F-Fluoroestradiol (FES) PET/CT imaging as biomarkers in patients with metastatic breast cancer
    Hunter, Natasha
    Peterson, Lanell M.
    Muzi, Mark
    Konnick, Eric Q.
    Reichel, Jonathan
    Kinahan, Paul
    Specht, Jennifer M.
    Yung, Rachel
    Gwin, William R.
    Linden, Hannah
    Tran, Christina
    CANCER RESEARCH, 2023, 83 (05)
  • [27] Evaluation of tumour heterogeneity by 18F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment
    Liu, Cheng
    Hu, Shihui
    Xu, Xiaoping
    Zhang, Yongping
    Wang, Biyun
    Song, Shaoli
    Yang, Zhongyi
    BREAST CANCER RESEARCH, 2022, 24 (01)
  • [28] To Identify Small Bowel Metastasis From Lobular Breast Cancer on 18F-Fluoroestradiol PET/CT Necessary to Adjust the Background Uptake Level
    Lu, Yang
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (02) : 192 - 193
  • [29] A Randomized Feasibility Study of 18F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor Rich Postmenopausal Breast Cancer
    Chae, Sun Young
    Kim, Sung-Bae
    Ahn, Sei Hyun
    Kim, Hye Ok
    Yoon, Dok Hyun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Han, Sangwon
    Oh, Seung Jun
    Lee, Sang Ju
    Kim, Hee Jeong
    Son, Byung Ho
    Gong, Gyungyub
    Lee, Hyo Sang
    Moon, Dae Hyuk
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (04) : 563 - 568
  • [30] 18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysis
    Matushita, Cristina S.
    Coelho, Francisco de Assis Romeiro Figueiroa Benicio
    Stasiak, Camila Edith Stachera
    Rodrigues, Denise Ferreira
    Pianta, Diego Bromfman
    Kurkowski, Flavia Dornelas
    Silva, Marcelo Moreira da
    de Souza, Sergio Augusto Lopes
    Lopes, Rafael Willain
    de Castro, Paulo Henrique Rosado
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69
12345